IL162459A0 - Dosage form with a core table of active ingredientsheathed in a compressed annular body of powder o r granular material, and process and toolin - Google Patents
Dosage form with a core table of active ingredientsheathed in a compressed annular body of powder o r granular material, and process and toolinInfo
- Publication number
- IL162459A0 IL162459A0 IL16245902A IL16245902A IL162459A0 IL 162459 A0 IL162459 A0 IL 162459A0 IL 16245902 A IL16245902 A IL 16245902A IL 16245902 A IL16245902 A IL 16245902A IL 162459 A0 IL162459 A0 IL 162459A0
- Authority
- IL
- Israel
- Prior art keywords
- ingredientsheathed
- toolin
- powder
- active
- dosage form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/005—Coating of tablets or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/34—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses for coating articles, e.g. tablets
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Mechanical Engineering (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34244201P | 2001-12-24 | 2001-12-24 | |
US36182102P | 2002-03-04 | 2002-03-04 | |
PCT/US2002/036081 WO2003057136A2 (en) | 2001-12-24 | 2002-11-12 | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
Publications (1)
Publication Number | Publication Date |
---|---|
IL162459A0 true IL162459A0 (en) | 2005-11-20 |
Family
ID=26993007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16245902A IL162459A0 (en) | 2001-12-24 | 2002-11-12 | Dosage form with a core table of active ingredientsheathed in a compressed annular body of powder o r granular material, and process and toolin |
Country Status (14)
Country | Link |
---|---|
US (2) | US7611722B2 (ja) |
EP (2) | EP2172192A1 (ja) |
JP (1) | JP4414228B2 (ja) |
KR (1) | KR100897837B1 (ja) |
CN (1) | CN1620284B (ja) |
BR (1) | BR0215413A (ja) |
CA (1) | CA2470495A1 (ja) |
EA (1) | EA006053B1 (ja) |
HU (1) | HUP0600680A3 (ja) |
IL (1) | IL162459A0 (ja) |
MX (1) | MXPA04006310A (ja) |
NO (1) | NO20043152L (ja) |
NZ (3) | NZ552514A (ja) |
WO (1) | WO2003057136A2 (ja) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2172192A1 (en) | 2001-12-24 | 2010-04-07 | Teva Pharmaceutical Industries Ltd. | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder of granular material, and process and tooling for producing it |
US20040052843A1 (en) * | 2001-12-24 | 2004-03-18 | Lerner E. Itzhak | Controlled release dosage forms |
AU2003217909C1 (en) * | 2002-03-04 | 2009-06-11 | Teva Pharmaceutical Industries Ltd. | Controlled release dosage forms |
CN1738600A (zh) * | 2002-11-12 | 2006-02-22 | 特瓦制药工业有限公司 | 用于口腔给药和舌下给药的替扎尼定药物组合物及剂型以及舌下或口腔给予替扎尼定的方法 |
NZ546662A (en) * | 2003-10-20 | 2009-03-31 | Teva Pharma | Composition and dosage form for sustained effect of levodopa |
CN1921866A (zh) * | 2004-02-19 | 2007-02-28 | 特瓦制药工业有限公司 | 使用雷洛昔芬和阿伦膦酸盐的改善的联合治疗 |
AU2011204852B2 (en) * | 2004-06-09 | 2013-01-10 | Glaxosmithkline Llc | Apparatus and method for pharmaceutical production |
TWI428271B (zh) * | 2004-06-09 | 2014-03-01 | Smithkline Beecham Corp | 生產藥物之裝置及方法 |
US20060002986A1 (en) * | 2004-06-09 | 2006-01-05 | Smithkline Beecham Corporation | Pharmaceutical product |
MX2007001058A (es) * | 2004-07-26 | 2007-04-16 | Teva Pharma | Formas de dosificacion con tableta nucleo recubierta entericamente. |
CN101888833A (zh) * | 2004-07-26 | 2010-11-17 | 特瓦制药工业有限公司 | 包含肠溶衣包被的芯片的剂型 |
JP2008507586A (ja) * | 2004-07-26 | 2008-03-13 | テバ ファーマシューティカル インダストリーズ リミティド | ラサグリンを含む、医薬投与剤 |
US20060024368A1 (en) * | 2004-07-30 | 2006-02-02 | Reza Fassihi | Compressed composite delivery system for release-rate modulation of bioactives |
US8022032B2 (en) * | 2004-11-19 | 2011-09-20 | Smithkline Beecham Corporation | Method for customized dispensing of variable dose drug combination products for individualizing of therapies |
US20070148238A1 (en) * | 2005-06-23 | 2007-06-28 | Spherics, Inc. | Dosage forms for movement disorder treatment |
US20070178149A1 (en) * | 2005-11-07 | 2007-08-02 | Moshe Flashner-Barak | Levodopa compositions |
US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
US8765178B2 (en) * | 2006-07-19 | 2014-07-01 | Watson Laboratories, Inc. | Controlled release formulations and associated methods |
WO2008027557A2 (en) | 2006-08-31 | 2008-03-06 | Spherics, Inc. | Topiramate compositions and methods of enhancing its bioavailability |
ES2312308T3 (es) | 2006-11-17 | 2013-03-26 | Supernus Pharmaceuticals, Inc. | Formulaciones de liberación sostenida de topiramato |
CA2673511A1 (en) * | 2006-12-22 | 2008-07-03 | Combinatorx, Incorporated | Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
GB0702974D0 (en) * | 2007-02-15 | 2007-03-28 | Jagotec Ag | Method and apparatus for producing a tablet |
US20130059062A1 (en) * | 2010-03-11 | 2013-03-07 | Ramakant Kashinath Gundu | Device For The Manufacture Of A Dosage Form With A Hole And Method Of Manufacture |
AU2011346757B2 (en) | 2010-12-22 | 2015-08-20 | Purdue Pharma L.P. | Encased tamper resistant controlled release dosage forms |
JP5638151B2 (ja) | 2010-12-23 | 2014-12-10 | パーデュー、ファーマ、リミテッド、パートナーシップ | 不正加工抵抗性の(tamperresistant)固形経口剤形 |
CA2830069C (en) | 2011-03-20 | 2019-11-12 | The University Of British Columbia | Therapeutic agent for emphysema and copd |
US20140227293A1 (en) | 2011-06-30 | 2014-08-14 | Trustees Of Boston University | Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1) |
WO2014123899A1 (en) | 2013-02-05 | 2014-08-14 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
DK3087980T3 (en) * | 2013-12-23 | 2019-02-18 | Xiaoguang Wen | DOUBLE LAYER TABLE AND METHOD OF PRODUCING THEREOF |
FR3021666B1 (fr) * | 2014-05-28 | 2017-12-08 | Eurotab | Tablette multicouches a cavite, dispositif et procede de compaction d'une telle tablette |
CA2987114A1 (en) | 2015-06-03 | 2016-12-08 | Triastek, Inc. | Method of 3d printing oral dosage forms having a drug in a compartment sealed by an erodible plug |
US10844154B2 (en) | 2015-11-20 | 2020-11-24 | Isp Investments Llc | Proliferous copolymers comprising lactamic moieties |
AU2018269544B2 (en) | 2017-05-17 | 2024-06-13 | Massachusetts Institute Of Technology | Self-righting articles |
US11541015B2 (en) | 2017-05-17 | 2023-01-03 | Massachusetts Institute Of Technology | Self-righting systems, methods, and related components |
US11571391B2 (en) | 2018-01-09 | 2023-02-07 | Triastek, Inc. | Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant |
WO2019246503A1 (en) * | 2018-06-22 | 2019-12-26 | Ideaz, Llc | Diphenyl tablets and methods of preparing the same |
CN113463047A (zh) * | 2021-08-18 | 2021-10-01 | 广东先导稀材股份有限公司 | 一种靶材制备电动辅助装置 |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US508915A (en) * | 1893-11-21 | Wabhinqton | ||
US36475A (en) * | 1862-09-16 | Improvement in machines for making horseshoes | ||
US1609460A (en) * | 1925-01-28 | 1926-12-07 | Western Electric Co | Apparatus for molding articles under high pressure |
US1806300A (en) * | 1930-02-01 | 1931-05-19 | Moraine Products Company | Briquetting machine |
US2027915A (en) * | 1933-01-27 | 1936-01-14 | Albert S Kux | Compressing machine |
US2573365A (en) * | 1947-10-04 | 1951-10-30 | Sylvania Electric Prod | Apparatus for fabricating insulating members for lamp bases and the like |
GB972128A (en) | 1960-01-21 | 1964-10-07 | Wellcome Found | Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets |
US3149375A (en) * | 1961-08-18 | 1964-09-22 | Corning Glass Works | Apparatus and method for molding cup-shaped bodies |
US3353215A (en) * | 1965-11-10 | 1967-11-21 | Haller John | Powdered material briquetting press |
US3593366A (en) * | 1968-12-11 | 1971-07-20 | Wolverine Pentronix | Multiple punch tool set for powder compacting press |
GB1242259A (en) * | 1968-12-13 | 1971-08-11 | Birmingham Small Arms Co Ltd | Improvements in or relating to compacting machines |
US3995631A (en) * | 1971-01-13 | 1976-12-07 | Alza Corporation | Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient |
US3977404A (en) * | 1975-09-08 | 1976-08-31 | Alza Corporation | Osmotic device having microporous reservoir |
US4061453A (en) * | 1975-10-06 | 1977-12-06 | Wolverine Aluminum Corporation | Tooling for a powder compacting press |
DE2604648C2 (de) * | 1976-02-04 | 1980-10-09 | Emil Korsch Spezialfabrik Fuer Komprimiermaschinen, 1000 Berlin | Rundlaufpresse |
JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
US4352648A (en) * | 1980-12-22 | 1982-10-05 | Toolmakers, Incorporated | Powdered metal press and tooling therefor |
US4443171A (en) * | 1982-04-14 | 1984-04-17 | Wesjay, Inc. | Multi-motion mechanical press |
US4639338A (en) * | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
GB8514666D0 (en) * | 1985-06-11 | 1985-07-10 | Coopers Animal Health | Agent delivery systems |
DK170473B1 (da) * | 1985-06-20 | 1995-09-11 | Daiichi Seiyaku Co | S(-)-pyridobenzoxazinforbindelser |
IT1188212B (it) * | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
US5088915A (en) * | 1988-06-08 | 1992-02-18 | Korsch Ohg Maschinenfabrik | Coated-core press |
IT1237904B (it) * | 1989-12-14 | 1993-06-18 | Ubaldo Conte | Compresse a rilascio a velocita' controllata delle sostanze attive |
US5071607A (en) | 1990-01-31 | 1991-12-10 | Alza Corporatino | Method and apparatus for forming a hole in a drug dispensing device |
KR920003605B1 (ko) * | 1990-03-27 | 1992-05-04 | 한국과학기술연구원 | 피페라지닐 퀴놀론 유도체의 제조방법 |
DE4019023A1 (de) * | 1990-06-14 | 1991-12-19 | Bayer Ag | Verfahren zur herstellung von chinolincarbonsaeuren |
DE4025484C1 (ja) | 1990-08-08 | 1991-10-10 | Korsch Maschfab | |
JPH07115233B2 (ja) * | 1990-08-10 | 1995-12-13 | 株式会社ヨシツカ精機 | 粉末成形プレス |
US5234646A (en) | 1990-08-30 | 1993-08-10 | Shionogi & Co., Ltd. | Method for molding powder under compression |
US5156850A (en) * | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
EP0546593B1 (en) * | 1991-10-30 | 1997-09-03 | Glaxo Group Limited | Multi-layered compositions containing histamine or serotonin antagonists |
US5277570A (en) * | 1992-03-30 | 1994-01-11 | Siggers David L | Press for pressing a compressible material |
JPH0798279B2 (ja) | 1992-11-05 | 1995-10-25 | 株式会社ヨシツカ精機 | 粉末成形プレスのパンチ接続方法および接続装置 |
US6406714B1 (en) * | 1992-12-02 | 2002-06-18 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids |
US5358941A (en) * | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
JP3345133B2 (ja) * | 1992-12-21 | 2002-11-18 | サンスター株式会社 | 練歯磨組成物 |
US6399592B1 (en) * | 1992-12-23 | 2002-06-04 | Merck & Co., Inc. | Bishphosphonate/estrogen synergistic therapy for treating and preventing bone loss |
JPH08505142A (ja) | 1992-12-23 | 1996-06-04 | メルク エンド カンパニー インコーポレーテッド | 骨損失を治療及び予防するためのビスホスホネート/エストロゲン療法 |
DE9306785U1 (de) | 1993-05-05 | 1993-07-08 | Kilian & Co. GmbH Maschinenfabrik, 5000 Köln | Rundlauf-Tablettenpresse |
US5653926A (en) * | 1993-09-10 | 1997-08-05 | Fuisz Technologies, Ltd. | Method and apparatus for forming compression dosage units |
US5431920A (en) * | 1993-09-21 | 1995-07-11 | Merck Frosst, Canada, Inc. | Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
AU5556994A (en) * | 1993-11-24 | 1995-06-13 | Stackpole Limited | Phased split die |
DE4401358C2 (de) | 1994-01-15 | 1995-11-23 | Korsch Pressen Gmbh | Vorrichtung zum Befestigen der Matrizen im Matrizentisch einer Rundlauf-Tablettiermaschine |
KR0125115B1 (ko) * | 1994-03-22 | 1997-12-05 | 김은영 | (-)피페라진 벤즈옥사진 유도체의 제조방법 |
DE9409108U1 (de) * | 1994-06-03 | 1994-08-04 | Wilhelm Fette Gmbh, 21493 Schwarzenbek | Preßstempel für eine Tablettiermaschine |
US5672364A (en) * | 1994-07-07 | 1997-09-30 | Sankyo Seisakusho Co. & Eisai Co., Ltd. | Apparatus for manufacturing tablets |
DE4431653C2 (de) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
US20010051616A1 (en) * | 1995-02-17 | 2001-12-13 | David B. Karpf | Method of lessening the risk of vertebral fractures |
KR19980702210A (ko) * | 1995-02-17 | 1998-07-15 | 폴락 돈나 엘 | 비척추골 골절의 위험률을 감소시키는 방법 |
TW287975B (en) * | 1995-11-16 | 1996-10-11 | Honda Motor Co Ltd | Method of and apparatus for manufacturing pressed powder body |
DE29520473U1 (de) * | 1995-12-22 | 1996-03-28 | Koch, Rudolf, 83646 Bad Tölz | Vorrichtung zur Herstellung von Tabletten |
US6620358B2 (en) * | 1996-07-03 | 2003-09-16 | Gunter Voss | Process for manufacturing tablets |
JP4098376B2 (ja) * | 1996-09-05 | 2008-06-11 | ビーエーエスエフ ソシエタス・ヨーロピア | 錠剤特性の優れた水溶性ビタミン組成物およびその製造法 |
US5994377A (en) * | 1996-10-21 | 1999-11-30 | Gilead Sciences, Inc. | Piperidine compounds |
ATE325606T1 (de) | 1996-11-25 | 2006-06-15 | Alza Corp | Dosisform mit ansteigender dosisfreisetzung |
CA2197267C (en) * | 1997-02-11 | 2000-02-08 | Yong Tao | Process for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
SK284690B6 (sk) | 1997-06-11 | 2005-09-08 | The Procter And Gamble Company | Ústna dávkovacia forma na zvýšenie ochrany horného tráviaceho traktu |
US5994329A (en) | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6015801A (en) * | 1997-07-22 | 2000-01-18 | Merck & Co., Inc. | Method for inhibiting bone resorption |
IL121623A (en) * | 1997-08-26 | 2000-06-29 | Unipharm Ltd | Process for the preparation of solid oral dosage forms comprising alendronic acid |
US20010046977A1 (en) * | 1997-11-25 | 2001-11-29 | Merck & Co., Inc. | Use of alendronate for the prevention of osteoporosis |
WO1999067809A1 (en) * | 1998-06-24 | 1999-12-29 | Merck & Co., Inc. | Compositions and methods for inhibiting bone resorption |
KR20000011247A (ko) | 1998-07-23 | 2000-02-25 | 김윤 | 다당류를이용한대장선택성약물전달조성물및약학제제 |
US6008207A (en) * | 1998-08-13 | 1999-12-28 | Merck & Co., Inc. | Anhydrous alendronate monosodium salt formulations |
WO2000012517A1 (en) * | 1998-08-27 | 2000-03-09 | Teva Pharmaceutical Industries Ltd. | Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
EP0998932A1 (de) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
US6414006B1 (en) * | 1998-10-15 | 2002-07-02 | Merck Frosst Canada & Co. | Methods for inhibiting bone resorption |
AU1525700A (en) * | 1998-11-19 | 2000-06-05 | Board Of Trustees Of The University Of Arkansas, The | Increasing bone strength with selected bisphosphonates |
IL144941A0 (en) | 1999-02-17 | 2002-06-30 | Teva Pharma | Novel process for preparing alendronic acid |
JP2003502373A (ja) * | 1999-06-23 | 2003-01-21 | メルク エンド カムパニー インコーポレーテッド | インテグリン受容体アンタゴニスト |
AR024462A1 (es) * | 1999-07-01 | 2002-10-02 | Merck & Co Inc | Tabletas farmaceuticas |
US6963008B2 (en) * | 1999-07-19 | 2005-11-08 | Teva Pharmaceutical Industries Ltd. | Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
ES2153794B1 (es) * | 1999-08-06 | 2001-10-16 | Medichem Sa | Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada. |
AU7743400A (en) * | 1999-10-04 | 2001-05-10 | Merck & Co., Inc. | Integrin receptor antagonists |
US6562974B2 (en) * | 2000-02-01 | 2003-05-13 | The Procter & Gamble Company | Process for making geminal bisphosphonates |
US20020151459A1 (en) * | 2000-02-25 | 2002-10-17 | Merck & Co., Inc. | Methods for identifying compounds useful for inhibiting farnesyl diphosphate synthase |
US6476006B2 (en) * | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
KR100463775B1 (ko) * | 2000-12-04 | 2004-12-29 | 가부시키가이샤 무라타 세이사쿠쇼 | 분말 공급 장치 및 분말 성형 장치 |
DE10114868C1 (de) * | 2001-03-26 | 2002-10-31 | Oxeno Olefinchemie Gmbh | Verfahren zur Herstellung von Diphosphinen und deren Verwendung |
TR200101250A2 (tr) * | 2001-05-10 | 2003-04-21 | E�S Eczaciba�I �Zg�N K�Myasal �R�Nler Sanay� A.�. | 4-amino-1-hidroksibutiliden-1,1-bifosfonik asit veya tuzlarının hazırlanmasına ilişkin proses |
WO2003007916A1 (en) | 2001-07-17 | 2003-01-30 | Teva Pharmaceutical Industries Ltd. | Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate |
US6645974B2 (en) * | 2001-07-31 | 2003-11-11 | Merck & Co., Inc. | Androgen receptor modulators and methods for use thereof |
GB2383042A (en) * | 2001-10-18 | 2003-06-18 | Cipla Ltd | Amorphous alendronate sodium |
US6863901B2 (en) * | 2001-11-30 | 2005-03-08 | Collegium Pharmaceutical, Inc. | Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
EP2172192A1 (en) | 2001-12-24 | 2010-04-07 | Teva Pharmaceutical Industries Ltd. | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder of granular material, and process and tooling for producing it |
ITMI20020146A1 (it) | 2002-01-29 | 2003-07-29 | Lyogen Ltd | Alendronato monosodico amorfo e processo per la sua preparazione |
DE10216997A1 (de) * | 2002-04-16 | 2003-10-30 | Merck Patent Gmbh | Verfahren zur Herstellung von Bis(perfluoralkyl)phosphinsäuren und deren Salze |
ITMI20020908A1 (it) * | 2002-04-29 | 2003-10-29 | Chemi Spa | Processo di preparazione di sodio alendronato |
ATE461205T1 (de) * | 2002-05-17 | 2010-04-15 | Teva Pharma | Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren |
US20050026871A1 (en) * | 2002-07-17 | 2005-02-03 | Moshe Flashner-Barak | Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative |
US20050113343A1 (en) * | 2003-10-14 | 2005-05-26 | Pliva - Research And Development Ltd. | Solid-state form of alendronate sodium and preparation thereof |
DE10350676A1 (de) * | 2003-10-30 | 2005-06-02 | Basf Ag | Verfahren zur Herstellung eines Alkenylphosphonsäure-Derivats |
US20050181043A1 (en) * | 2004-02-12 | 2005-08-18 | Indranil Nandi | Alendronate salt tablet compositions |
-
2002
- 2002-11-12 EP EP09180574A patent/EP2172192A1/en not_active Withdrawn
- 2002-11-12 JP JP2003557495A patent/JP4414228B2/ja not_active Expired - Fee Related
- 2002-11-12 MX MXPA04006310A patent/MXPA04006310A/es not_active Application Discontinuation
- 2002-11-12 EP EP02789567A patent/EP1465606A4/en not_active Withdrawn
- 2002-11-12 BR BR0215413-7A patent/BR0215413A/pt not_active IP Right Cessation
- 2002-11-12 IL IL16245902A patent/IL162459A0/xx unknown
- 2002-11-12 EA EA200400862A patent/EA006053B1/ru not_active IP Right Cessation
- 2002-11-12 CA CA002470495A patent/CA2470495A1/en not_active Abandoned
- 2002-11-12 NZ NZ552514A patent/NZ552514A/en not_active IP Right Cessation
- 2002-11-12 KR KR1020047010037A patent/KR100897837B1/ko not_active IP Right Cessation
- 2002-11-12 CN CN028282361A patent/CN1620284B/zh not_active Expired - Fee Related
- 2002-11-12 WO PCT/US2002/036081 patent/WO2003057136A2/en active IP Right Grant
- 2002-11-12 NZ NZ552513A patent/NZ552513A/en not_active IP Right Cessation
- 2002-11-12 HU HU0600680A patent/HUP0600680A3/hu unknown
- 2002-11-12 NZ NZ534104A patent/NZ534104A/en not_active IP Right Cessation
-
2003
- 2003-04-21 US US10/419,536 patent/US7611722B2/en not_active Expired - Fee Related
-
2004
- 2004-07-23 NO NO20043152A patent/NO20043152L/no not_active Application Discontinuation
- 2004-10-29 US US10/978,246 patent/US20050112202A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EA200400862A1 (ru) | 2004-12-30 |
EP1465606A2 (en) | 2004-10-13 |
HUP0600680A2 (en) | 2007-02-28 |
KR20040073512A (ko) | 2004-08-19 |
JP2005517678A (ja) | 2005-06-16 |
WO2003057136A3 (en) | 2004-02-12 |
BR0215413A (pt) | 2004-12-14 |
AU2002352613A1 (en) | 2003-07-24 |
CA2470495A1 (en) | 2003-07-17 |
US20050112202A1 (en) | 2005-05-26 |
NO20043152L (no) | 2004-09-02 |
HUP0600680A3 (en) | 2008-04-28 |
MXPA04006310A (es) | 2005-04-19 |
NZ552513A (en) | 2008-08-29 |
EP1465606A4 (en) | 2009-04-22 |
CN1620284A (zh) | 2005-05-25 |
JP4414228B2 (ja) | 2010-02-10 |
NZ534104A (en) | 2007-03-30 |
NZ552514A (en) | 2008-08-29 |
EP2172192A1 (en) | 2010-04-07 |
EA006053B1 (ru) | 2005-08-25 |
US20030206954A1 (en) | 2003-11-06 |
WO2003057136A2 (en) | 2003-07-17 |
US7611722B2 (en) | 2009-11-03 |
KR100897837B1 (ko) | 2009-05-15 |
CN1620284B (zh) | 2010-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL162459A0 (en) | Dosage form with a core table of active ingredientsheathed in a compressed annular body of powder o r granular material, and process and toolin | |
HUP0203885A3 (en) | Novel tiotropium-containing inhalation powder, process for its preperation and its use | |
HUP0402392A3 (en) | Container for a flowable product, process of manufacture and the use thereof | |
IL153167A0 (en) | Phenyl derivatives, a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy | |
HK1060566A1 (en) | Anticholinergic agents that can be used as medicaments and method for the production thereof | |
HK1068540A1 (en) | Crystalline anticholinergic, method for its production, and use thereof in the production of a drug | |
HUP0203198A3 (en) | Pharmaceutical composition comprising a tramadol material and an anticonvulsant drug, process for its preparation and its use | |
IL166747A0 (en) | Water-soluble iron-carbohydrate complexes production thereof and medicaments containing said complexes | |
AU7624801A (en) | Silicone rubber in the form of a finely divided powder, method for the production and the use of the same | |
EP1418272A4 (en) | PACKAGING MATERIAL AND CONTAINER | |
IL153920A (en) | Somatostatin analogues, processes for their production, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for therapy | |
EP1249475A4 (en) | INORGANIC OXIDE POWDER WITH MODIFIED SURFACE, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF | |
HK1046236A1 (zh) | 迅速溶解的劑量形式及其生產方法 | |
HUP0203553A3 (en) | Compressed tablet composition comprising a nsaid and process for its preparation | |
HK1065705A1 (en) | Method for manufacturing a low dose pharmaceuticalcomposition having uniform drug distribution and potency | |
EP1193723A4 (en) | FERRIT MAGNETIC POWDER, SINTERED MAGNETIC REFERENCE, LAMINATED FERRITE PART AND MANUFACTURING METHOD OF A PART | |
GB2396627B (en) | Composites comprising superabsorbent materials having a bimodal particle size distribution and methods of making the same | |
EP1510266A4 (en) | YARN MATERIALS FOR SINTERED DIAMOND BODIES AND PIPE FOR SINTERED DIAMOND BODIES | |
IL158412A0 (en) | A method for increasing the compactability of an active ingredient and a process for producing a solid dosage form having a high active ingredient drug load | |
HUP0302208A3 (en) | Deltamethrin-containing, water-dispersible granular material, production and use thereof | |
IL161766A0 (en) | Process for reacting alkaloids and use of the reaction products in the preparation of medicaments | |
AU2002238805A1 (en) | A head and a process for filling containers with powder material | |
HK1051860A1 (en) | 3-Phenyl-3,7-diazabicyclo Ä3,3,1Ünonane compounds and process for their preparation and medicaments containing these compounds | |
HK1080716A1 (en) | A use of desmethylselegiline in manufacture of medicine for preventing and treating peripheral neuropathy | |
GB0224848D0 (en) | Packaging and packaging material |